Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

Fig. 1

Causal model for the effect of concomitant medications on Immunotherapy Response and Overall Survival. Numbers along edges refer to references supporting the connection. Hypothesized dominant pathways are shown in heavily-weighted edges [1,2,3, 9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32].

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us